Chad’s practice focuses on the defense of pharmaceutical manufacturers in complex litigation in federal and state courts throughout the United States.
The products Chad has defended include antidepressants, attention-deficit/hyperactivity disorder medication, diethylstilbestrol, automatic implantable cardioverter-defibrillators, hormone replacement therapy and over-the-counter medications.
Chad's prior experience in the firm includes e-discovery issues concerning data privacy and protection. He also has experience working on privacy issues involving data protection regulations in the European Union, Latin America, North America and Australia.
While in law school, he served as the managing editor of the Creighton Law Review, was listed in two editions of Who's Who Among American Law Students and received the highest grade award in his Public International Law class.
A Missed Opportunity to Definitively Apply the Central Hudson Test, 26 Creighton Law Review 1155 (1993).